Cost comparison of surgery vs organ preservation for laryngeal cancer

Archives of Otolaryngology - Head and Neck Surgery

Volumn 131, Issue 1, 2005, Pages 21-26

  Davis, Greg E ^a,b   Schwartz, Seth R ^a   Veenstra, David L ^a   Yueh, Bevan ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; COST MINIMIZATION ANALYSIS; DECISION MAKING; FEBRILE NEUTROPENIA; FISTULA; HEALTH CARE; HEALTH CARE COST; HEART DISEASE; HUMAN; INTERMETHOD COMPARISON; LARYNGECTOMY; LARYNX CANCER; MAJOR CLINICAL STUDY; ORGAN PRESERVATION; PERIOPERATIVE PERIOD; PNEUMONIA; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; RESPIRATORY TRACT DISEASE; SALVAGE THERAPY; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; WOUND;

ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; COSTS AND COST ANALYSIS; DECISION SUPPORT TECHNIQUES; FLUOROURACIL; HUMANS; LARYNGEAL NEOPLASMS; LARYNGECTOMY; MODELS, THEORETICAL; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT;

EID: 12144264400     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.131.1.21     Document Type: Article

References (35)

1. Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 1991;324:1685-1690.
2. Terrell JE, Fisher SG, Wolf GT; Veterans Affairs Laryngeal Cancer Study Group. Long-term quality of life after treatment of laryngeal cancer. Arch Otolaryngol Head Neck Surg. 1998;124:964-971.
3. Muller R, Paneff J, Kollner V, Koch R. Quality of life of patients with laryngeal carcinoma: a post-treatment study. Eur Arch Otorhinolaryngol. 2001;258:276-280.
4. Finizia C, Hammerlid E, Westin T, Lindstrom J. Quality of life and voice in patients with laryngeal carcinoma: a posttreatment comparison of laryngectomy (salvage surgery) versus radiotherapy. Laryngoscope. 1998;108:1566-1573.
5. Major MS, Bumpous JM, Flynn MB, Schill K. Quality of life after treatment for advanced laryngeal and hypopharyngeal cancer. Laryngoscope. 2001;111:1379-1382.
6. List MA, Ritter-Sterr CA, Baker TM, et al. Longitudinal assessment of quality of life in laryngeal cancer patients. Head Neck. 1996;18:1-10.
7. Ringash J, Redelmeier DA, O'Sullivan B, Bezjak A. Quality of life and utility in irradiated laryngeal cancer patients. Int J Radiat Oncol Biol Phys. 2000;47:875-881.
8. Brown MM. Health care economic analyses. Curr Opin Ophthalmol. 2003;14:117-121.
9. Shemen LJ, Spiro RH. Complications following laryngectomy. Head Neck Surg. 1986;8:185-191.
10. Redaelli de Zinis LO, Ferrari L, Tomenzoli D, Premoli G, Parrinello G, Nicolai P. Postlaryngectomy pharyngocutaneous fistula: incidence, predisposing factors, and therapy. Head Neck. 1999;21:131-138.
11. Weber RS, Berkey BA, Forastiere A, et al. Outcome of salvage total laryngectomy following organ preservation therapy: the Radiation Therapy Oncology Group trial 91-11. Arch Otolaryngol Head Neck Surg. 2003;129:44-49.
12. Leon X, Quer M, Orus C, Lopez M, Gras JR, Vega M. Results of salvage surgery for local or regional recurrence after larynx preservation with induction chemotherapy and radiotherapy. Head Neck. 2001;23:733-738.
13. Sassler AM, Esclamado RM, Wolf GT. Surgery after organ preservation therapy: analysis of wound complications. Arch Otolaryngol Head Neck Surg. 1995;121:162-165.
14. Caponigro F, Cornella P, Marcolin P, et al. A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5-fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neck. Cancer. 1999;85:952-959.
15. Mathew JT, D'Souza GA, Kilpadi AB. Respiratory complications in postoperative patients. J Assoc Physicians India. 1999;47:1086-1088.
16. Fogarty BJ, Khan K, Ashall G, Leonard AG. Complications of long operations: a prospective study of morbidity associated with prolonged operative time (>6h). Br J Plast Surg. 1999;52:33-36.
17. Goodwin WJ Jr. Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means? Laryngoscope. 2000;110(suppl 93, pt 2):1-18.
18. Myers EN, Wagner RL, Johnson JT. Microlaryngoscopic surgery for T1 glottic lesions: a cost-effective option. Ann Otol Rhinol Laryngol. 1994;103:28-30.
19. Arnold DJ, Funk GF, Karnell LH, et al. Laryngeal cancer cost analysis: association of case-mix and treatment characteristics with medical charges. Laryngoscope. 2000;110:1-7.
20. Yueh B, Weaver EM, Bradley EH, et al. A critical evaluation of critical pathways in head and neck cancer. Arch Otolaryngol Head Neck Surg. 2003;129:89-95.
21. Gates GA, Ryan W, Cooper JC Jr, et al. Current status of laryngectomee rehabilitation, I: results of therapy. Am J Otolaryngol. 1982;3:1-7.
22. Laramore GE. T3N0M0 glottic cancer: are more treatment modalities necessarily better? Int J Radiat Oncol Biol Phys. 1995;31:423-425.
23. Vokes EE, Schilsky RL, Choi KE, et al. A randomized study of inpatient versus outpatient continuous infusion chemotherapy for patients with locally advanced head and neck cancer. Cancer. 1989;63:30-36.
24. Bailey BJ, Stiernberg CM, Quinn FB. Glottic carcinoma. In: Meyers AD, Eiseman B, eds. Cost-effective Otolaryngology. Philadelphia, Pa: BC Decker; 1990:157-172.
25. Rosenman M, Madsen K, Hui S, Breitfeld PP. Modeling administrative outcomes in fever and neotropenia: clinical variables significantly influence length of stay and hospital charges. J Pediatr Hematol Oncol. 2002;24:263-268.
26. Chen AY, Callender D, Mansyur C, Reyna KM, Limitone E, Goepfert H. The impact of clinical pathways on the practice of head and neck oncologic surgery: the University of Texas M. D. Anderson Cancer Center experience. Arch Otolaryngol Head Neck Surg. 2000;126:322-326.
27. Centers for Medicare & Medicaid Services. Diagnostic Related Group Manual. Washington, DC: Dept of Health and Human Services; 2000.
28. Naglie G, Krahn MD, Naimark D, Redelmeier DA, Detsky AS. Primer on medical decision analysis: part 3: estimating probabilities and utilities. Med Decis Making. 1997;17:136-141.
29. Krahn MD, Naglie G, Naimark D, Redelmeier DA, Detsky AS. Primer on medical decision analysis: part 4: analyzing the model and interpreting the results. Med Decis Making. 1997;17:142-151.
30. Newman JP, Terris DJ, Pinto HA, Fee WE Jr, Goode RL, Goffinet DR. Surgical morbidity of neck dissection after chemoradiotherapy in advanced head and neck cancer. Ann Otol Rhinol Laryngol. 1997;106:117-122.
31. Kezirian EJ, Yueh B. Accuracy of terminology and methodology in economic analyses in Otolaryngology. Otolaryngol Head Neck Surg. 2001;124:496-502.
32. Health Care Financing Administration. Prospective Payment System: Standardizing File. Washington, DC: Dept of Health and Human Services; 2002.
33. Leon X, Quer M, Orus C, Lopez-Pousa A, Pericay C, Vega M. How much does it cost to preserve a larynx? an economic study. Eur Arch Otorhinolaryngol. 2000; 257:72-76.
34. McNeil BJ, Pauker SG. Decision analysis for public health: principles and illustrations. Annu Rev Public Health. 1984;5:135-161.
35. Lusted LB. General problems in medical decision making with comments on ROC analysis. Semin Nucl Med. 1978;8:299-306.